Pharmacological management of COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) pandemic has brought the world to a standstill and is the largest public health crisis in the world in the present generation. As the cases continue to increase globally, and more patients are developing severe disease, large volumes of...
Main Authors: | Veena Raghunathan, Maninder Singh Dhaliwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Pediatric Critical Care |
Subjects: | |
Online Access: | http://www.jpcc.org.in/article.asp?issn=2349-6592;year=2020;volume=7;issue=7;spage=42;epage=48;aulast=Raghunathan |
Similar Items
-
COVID-19: An Update About the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-05-01) -
COVID-19: A Brief Overview of the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-04-01) -
The Effect of Proposed Drugs in the Treatment of Patients with COVID- 19: A Systematic Review
by: Amir Shakarami, et al.
Published: (2020-11-01) -
Clinical evaluation of selected Pharmacological Treatments used for Coronavirus (COVID-19) pandemic
by: hasan mohammed altemimy
Published: (2020-06-01) -
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
by: Stanković Biljana, et al.
Published: (2020-01-01)